Evolution of the Average Target: MaxLinear, Inc.

Evolution of the Target Price: MaxLinear, Inc.

Changes in Analyst Recommendations: MaxLinear, Inc.

b.AAhwU3xs6Z7yFbK08ND_jzH-Yl2E1K6dNmgixghCcWY.RV4YOyktuu_EWPbXm6q4xHO9KQupuZbrXjBOrTgpA0szfEEhSlu505hbhg~f1ca3c743424395025b6a3e805eaeb7c
04-29 MaxLinear Shares Rise After Upgrade From Loop Capital MT
04-29 Loop Capital Upgrades MaxLinear to Buy From Hold, Adjusts Price Target to $75 From $17 MT
04-24 Deutsche Bank Adjusts MaxLinear Price Target to $40 From $18, Maintains Hold Rating MT
01-30 Deutsche Bank Raises Price Target on MaxLinear to $18 From $17, Keeps Hold Rating MT
25-10-24 Deutsche Bank Raises Price Target on MaxLinear to $17 From $15, Keeps Hold Rating MT
25-07-24 Deutsche Bank Adjusts MaxLinear Price Target to $15 From $13, Maintains Hold Rating MT
25-04-24 Deutsche Bank Adjusts Price Target on MaxLinear to $13 From $15, Maintains Hold Rating MT
25-04-07 Deutsche Bank Adjusts MaxLinear Price Target to $15 From $18, Maintains Hold Rating MT
25-01-30 Deutsche Bank Adjusts MaxLinear Price Target to $18 From $17, Maintains Hold Rating MT
24-10-01 Susquehanna Downgrades MaxLinear to Neutral From Positive, Price Target is $15 MT
24-07-25 Susquehanna Adjusts Price Target on MaxLinear to $26 From $30, Maintains Positive Rating MT
24-07-25 Benchmark Adjusts Price Target on MaxLinear to $22 From $28, Maintains Buy Rating MT
24-07-25 Needham Downgrades MaxLinear to Hold From Buy MT
24-07-25 Deutsche Bank Adjusts MaxLinear Price Target to $17 From $19, Maintains Hold Rating MT
24-07-18 Stifel Adjusts MaxLinear Price Target to $30 From $26, Maintains Buy Rating MT
24-07-17 Susquehanna Adjusts Price Target on MaxLinear to $30 From $25, Maintains Positive Rating MT
24-04-15 Benchmark Raises Price Target on MaxLinear to $28 From $23, Maintains Buy Rating MT
24-02-01 Needham Cuts MaxLinear's Price Target to $25 From $28, Keeps Buy Rating MT
24-02-01 Deutsche Bank Adjusts MaxLinear Price Target to $19 From $21, Maintains Hold Rating MT
24-01-03 Wells Fargo Downgrades MaxLinear to Equalweight From Overweight, Cuts Price Target to $25 From $35 MT
23-10-26 Susquehanna Adjusts Price Target on MaxLinear to $22 From $30, Maintains Positive Rating MT
23-10-26 Deutsche Bank Adjusts MaxLinear Price Target to $20 From $23, Maintains Hold Rating MT
23-10-26 Wells Fargo Adjusts Price Target on MaxLinear to $35 From $45, Maintains Overweight Rating MT
23-10-26 Needham Adjusts Price Target on MaxLinear to $28 From $34, Maintains Buy Rating MT
23-10-26 Roth MKM Downgrades MaxLinear to Neutral From Buy, Adjusts Price Target to $18 From $35 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+59.03%
+43.19%
+35.12%
+49.02%
+57.92%
+101.34%
+34.57%
+26.3%
+18.87%
Average +47.26%
Weighted average by Cap. +46.30%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
59.45USD
Average target price
94.55USD
Spread / Average Target
+59.03%
High Price Target
125.00USD
Spread / Highest target
+110.26%
Low Price Target
40.00USD
Spread / Lowest Target
-32.72%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MXL Stock
  4. Consensus MaxLinear, Inc.